Search results
Targeted cancer medicine able to cure most aggressive cases with ‘remarkable results’
The Independent via Yahoo News· 3 days agoCancer treatment tailored to an individual child’s condition can lead to significant remission, a...
Did ancient Egyptians use surgery to treat brain cancer?
Al Jazeera· 1 day agoAncient Egyptians may have tried to treat cancer with surgery more than 4,000 years ago, a study has...
Your Pancreas Is More Important Than You Know
Men's Health via AOL· 6 days agoThe pancreas is involved in digestion and managing blood sugar. When it's is in trouble, diabetes, pancreatitis, or pancreatic cancer can result. How to...
The Zacks Analyst Blog Highlights Roche, Wells Fargo, General Aerospace and Key Tronic
Zacks via Yahoo Finance· 4 days agoThis, in turn, has significantly affected its top line, even though the diagnostics base business...
Cathie Wood Owns These 2 AI Stocks. Should You?
Motley Fool via Yahoo Finance· 6 days agoMeanwhile, the company generates little revenue and is consistently unprofitable, like most clinical-stage drugmakers. The biotech has attracted the...
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for...
Morningstar· 4 days agoABBV-383 is a B-cell maturation antigen (BCMA) bispecific antibody T-cell engager being evaluated in relapsed/refractory multiple myeloma (r/r MM)The CERVINO Phase 3 trial will evaluate the efficacy, safety, and tolerability of ABBV-383 monotherapy
Newswise Expert | Jonathan Marron, Dana-Farber Cancer Institute
Newswise· 5 days agoMuch of Dr. Marron's current work focuses on patient, parent and physician decision-making regarding pediatric precision cancer medicine. He also teaches ...
MU alum, former Ameren employee to direct NextGen MU Research Reactor construction
Columbia Daily Tribune via Yahoo News· 3 days ago“The work that we do at MURR saves and improves thousands of lives each and every day,” Choi said in...
The MUHC Foundation’s Le Bal Rouge Gala Raises a record-breaking $2,050,000 million for Cancer...
Digital Journal· 5 days agoThe MUHC Foundation backs the most innovative cancer researchers in the province. This year’s Le Bal Rouge gala supported the Cancer Research Program of the Research Institute of the McGill ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 6 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company paid nearly $5 billion ...